⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8117281 | 0.97 | TSHR (0.37) | — | |
| SCHEMBL27949630 | 0.97 | — | — | |
| SCHEMBL3447447 | 0.89 | — | — | |
| SCHEMBL3287225 | 0.84 | ALDH1A1 (0.33) | — | |
| SCHEMBL11304871 | 0.81 | PAOX (0.38) | — | |
| SCHEMBL1166877 | 0.78 | — | — | |
| SCHEMBL6580621 | 0.78 | — | — | |
| SCHEMBL7875848 | 0.77 | — | — | |
| SCHEMBL2933239 | 0.76 | — | — | |
| SCHEMBL23297342 | 0.76 | TSHR (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| WO-2022026960-A1 | COMPOSITIONS AND METHODS RELATED TO EXCIPIENTS AND CANNABINOID FORMULATIONS | Natural Extraction Systems, LLC (US) | 2022-02-03 | — | — | WO | claimed |
| US-20210360947-A1 | COMPOSITIONS AND METHODS RELATED TO EXCIPIENTS AND CANNABINOID FORMULATIONS | Natural Extraction Systems, LLC | 2021-11-25 | — | — | US | claimed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| EP-1802293-A4 | ORALLY EFFECTIVE CANNABINOID ANALOGS | PHARMOS CORP (US) | 2009-04-29 | — | — | EP | claimed |
| US-20090068143-A1 | ORALLY EFFECTIVE CANNABINOID ANALOGS | PHARMOS CORPORATION (US) | 2009-03-12 | — | — | US | claimed |
| EP-1802293-A2 | ORALLY EFFECTIVE CANNABINOID ANALOGS | PHARMOS CORPORATION (US) | 2007-07-04 | — | — | EP | claimed |
| WO-2006043260-A2 | ORALLY EFFECTIVE CANNABINOID ANALOGS | PHARMOS CORPORATION (US) | 2006-04-27 | — | — | WO | claimed |
| US-20050020544-A1 | Bicyclic CB2 cannabinoid receptor ligands | PHARMOS CORPORATION | 2005-01-27 | — | — | US | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | disclosed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | disclosed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | disclosed |
| CN-102224452-B | Diamine, polyimide, liquid crystal aligning agent, and liquid crystal alignment film | NISSAN CHEMICAL IND LTD | 2014-07-09 | — | — | CN | disclosed |
| CN-103619817-A | Novel bicyclic nitrogen containing heteroaryl TGR5 receptor modulators | BRISTOL MYERS SQUIBB CO | 2014-03-05 | — | — | CN | disclosed |
| EP-1802293-A4 | ORALLY EFFECTIVE CANNABINOID ANALOGS | PHARMOS CORP (US) | 2009-04-29 | — | — | EP | disclosed |
| US-20090068143-A1 | ORALLY EFFECTIVE CANNABINOID ANALOGS | PHARMOS CORPORATION (US) | 2009-03-12 | — | — | US | disclosed |
| EP-1802293-A2 | ORALLY EFFECTIVE CANNABINOID ANALOGS | PHARMOS CORPORATION (US) | 2007-07-04 | — | — | EP | disclosed |
| WO-2006043260-A2 | ORALLY EFFECTIVE CANNABINOID ANALOGS | PHARMOS CORPORATION (US) | 2006-04-27 | — | — | WO | disclosed |
| US-20050020544-A1 | Bicyclic CB2 cannabinoid receptor ligands | PHARMOS CORPORATION | 2005-01-27 | — | — | US | disclosed |